Suitable candidates Adults with stable body weight, ideally within 15% of their healthy weight range BMI generally 30 (some practitioners extend to 35 for specific indications) Localised adiposity at the target site, distinct from overall body fat distribution Good to adequate skin elasticity at the treatment area Realistic expectations established clearly during consultation No active skin conditions, infection or inflammation at the treatment area Contraindications Pregnancy or breastfeeding Lipodystrophy Severe hepatic or renal impairment Active infection at the treatment area defer until resolved Known hypersensitivity to any product component Anticoagulant therapy or bleeding disorder assess individually Clinical communication point: The distinction between contouring and weight loss must be established in writing at consultation
lower stress to help reduce stress-related food cravings*
They curb appetite, slow digestion, and improve blood sugar control
Jessica Massarone stopped having the drug dreams that left her too frightened to sleep
Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses
Vitrified specimens and data collection Holey TEM grids (Ultrafoil R1.2/1.3 Au 300 gold foil grids, Quantifoil GmbH) were pre-washed with chloroform prior to glow discharged
